Interpace Biosciences (IDXG) Price/Sales Ratio
Market Cap: $8.83M
Avg Volume: 7.93K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is Interpace Biosciences's Price/Sales Ratio?
- Interpace Biosciences's trailing twelve month (TTM) Price/Sales ratio is 0.21.
- Interpace Biosciences's annual Price/Sales ratio as of today is 0.12.
- Interpace Biosciences's quarterly Price/Sales ratio is 0.39.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Interpace Biosciences's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: 5.81
- Quarterly: 0.57
- TTM: 3.13
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: -0.31
- Quarterly: -0.37
- TTM: -0.70
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: 1.23
- Quarterly: 3.33
- TTM: 2.44
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: -0.05
- Quarterly: 0.00
- TTM: 0.03
These metrics provide insights into Interpace Biosciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
0.12
Quarterly Price/Sales Ratio
0.39
TTM Price/Sales Ratio
0.21
Interpace Biosciences Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Interpace Biosciences Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2023 | 0.12 | 5.81 | -0.31 | 1.23 | -0.05 |
| 2022 | 0.14 | -0.75 | -0.07 | -0.57 | 0.01 |
| 2021 | 0.75 | -2.09 | -0.73 | -3.54 | 0.05 |
| 2020 | 0.39 | -0.48 | -0.43 | -0.87 | 0.06 |
| 2019 | 0.78 | -0.70 | 1.44 | -0.99 | -0.01 |
| 2018 | 1.03 | -1.85 | 0.68 | -2.60 | 0.04 |
| 2017 | 1.01 | -1.31 | 0.40 | -1.05 | 0.02 |
| 2016 | 0.61 | -0.96 | 1.22 | -0.89 | 0.03 |
| 2015 | 0.76 | -0.63 | 0.55 | -0.36 | 0.02 |
| 2014 | 0.22 | -1.66 | 1.33 | -1.63 | 0.00 |